Pathogenicity of GB virus C on virus hepatitis and hemodialysis patients

Table 1 Comparison of biochemistry characteristics in all types of patients with or without GBV-C infection

Group	n	ALT/IU·L-1	AST/IU·L-1	TBil/μmol·L-1	DBil/μmol·L-1	Tp/g·L-1
Acute hepatitis B
GBV-C RNA(+)	13	1173.92 ± 961.98	565.69 ± 405.32	5.18 ± 3.47	3.54 ± 2.66	68.44 ± 12.14
GBV-C RNA(-)	33	1380.27 ± 906.14	620.06 ± 405.32	6.52 ± 6.61	4.57 ± 4.51	67.84 ± 12.42
Chronic hepatitis B
GBV-C RNA(+)	24	366.33 ± 237.36	289.42 ± 201.32	6.48 ± 7.34	3.98 ± 4.50	71.30 ± 8.57
GBV-C RNA(-)	35	312.91 ± 432.82	227.29 ± 292.17	3.29 ± 5.58	2.21 ± 4.24	71.06 ± 7.66
Liver cirrhosis
GBV-C RNA(+)	30	71.67 ± 74.13	96.73 ± 87.21	5.54 ± 7.44	3.62 ± 5.33	66.46 ± 8.75
GBV-C RNA(-)	34	92.68 ± 80.33	106.15 ± 94.81	7.67 ± 10.30	5.20 ± 5.80	62.58 ± 10.99
Total
GBV-C RNA(+)	67	400.51 ± 585.36	255.22 ± 301.71	5.73 ± 6.81	3.69 ± 4.46	68.80 ± 9.61
GBV-C RNA(-)	102	578.63 ± 807.04	314.98 ± 345.05	5.85 ± 7.85	3.87 ± 4.80	67.21 ± 10.92

No significant difference (P > 0.05) was found in all the biochemistry characteristics between hepatitis B patients with or without GBV-C infection.